Financings in Brief: Sonus Pharmaceuticals
This article was originally published in The Gray Sheet
Executive Summary
Sonus Pharmaceuticals: Raises $19.4 mil. in recently completed initial public offering of 3.3 mil. shares of common stock at $7 each. The shares sold included the initial 2.85 mil. shares offered plus the entire underwriters' over-allotment option of 427,000 shares ("The Gray Sheet" Oct. 16, p. 6). The firm now has about 8.4 mil. shares outstanding. Underwriters were Hambrecht & Quist, Montgomery Securities, and UBS Securities...